Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 7/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | CES2 | O00748 | 4/20 | 0.42 |
| ▸ | SRC | P12931 | 1/20 | 0.42 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | PARP1 | P09874 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2159286 | 0.85 | SMN1; SMN2 (0.47) | SMN1; SMN2HIF1ACES1CYP1A2MEN1 | |
| SCHEMBL10616915 | 0.82 | HIF1A (0.52) | SMN1; SMN2HIF1ACES1MEN1KMT2A | |
| SCHEMBL1507308 | 0.82 | HIF1A (0.52) | SMN1; SMN2HIF1ACES1CYP1A2MEN1 | |
| SCHEMBL1507309 | 0.82 | HIF1A (0.52) | SMN1; SMN2HIF1ACES1CYP1A2MEN1 | |
| SCHEMBL10662179 | 0.82 | CES1 (0.45) | SMN1; SMN2HIF1ACES1KMT2ACES2 | |
| SCHEMBL11403866 | 0.82 | CES1 (0.45) | SMN1; SMN2HIF1ACES1KMT2ACES2 | |
| SCHEMBL27717847 | 0.82 | LMNA (0.51) | SMN1; SMN2CYP1A2KMT2ACYP3A4TDP1 | |
| SCHEMBL28194587 | 0.81 | SMN1; SMN2 (0.47) | SMN1; SMN2HIF1ACES1CYP1A2MEN1 | |
| SCHEMBL4878730 | 0.81 | SMN1; SMN2 (0.50) | SMN1; SMN2HIF1ACES1CYP1A2MEN1 | |
| SCHEMBL2161616 | 0.81 | HIF1A (0.50) | SMN1; SMN2HIF1ACES1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010019469-A2 | PREPARATION OF (S)-2-AMINOBUTYRIC ACID | DR. REDDY'S LABORATORIES LTD. (IN) | 2010-02-18 | — | — | WO | claimed |
| EP-3878287-B1 | APPLICATION OF ACYLATED DERIVATIVE OF AMINO ACID IN PREPARATION OF ANIMAL FEED ADDITIVE | PENG XIANFENG (CN) | 2026-03-11 | — | — | EP | disclosed |
| US-20250241340-A1 | APPLICATION OF ACYLATED DERIVATIVE OF AMINO ACID IN PREPARATION OF ANIMAL FEED ADDITIVE | Anipha Technologies Pty Ltd (AU) | 2025-07-31 | — | — | US | disclosed |
| US-20220007684-A1 | APPLICATION OF ACYLATED DERIVATIVE OF AMINO ACID IN PREPARATION OF ANIMAL FEED ADDITIVE | Anipha Technologies Pty Ltd (AU) | 2022-01-13 | — | — | US | disclosed |
| EP-3878287-A1 | APPLICATION OF ACYLATED DERIVATIVE OF AMINO ACID IN PREPARATION OF ANIMAL FEED ADDITIVE | Peng, Xianfeng (CN) | 2021-09-15 | — | — | EP | disclosed |
| CN-109070051-A | Composite mode adsorbing medium, its method made and used with composite mode ligand | 赛多利斯司特蒂姆生物工艺公司 | 2018-12-21 | — | — | CN | disclosed |
| US-20100105681-A1 | 2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES AS VLA-4 INHIBITORS | LASSOIE MARIE-AGNES | 2010-04-29 | — | — | US | disclosed |
| US-7638630-B2 | Very Late Antigen-4 dependent inflammatory disease; asthma, allergic rhinitis, sinusitis, conjunctivitis, food allergy, inflammatory skin disorders, autoimmune disorders, or atherosclerosis, inflammatory skin disorder; methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-hydroxy-2-propenoate | UCB PHARMA S.A. (BE) | 2009-12-29 | — | — | US | disclosed |
| US-20080064720-A1 | 2,6-Quinolinyl And 2,6-Naphthyl Derivatives, Processes For Preparing Them And Their Uses As Vla-4 Inhibitors | UCB, S.A. (BE) | 2008-03-13 | — | — | US | disclosed |
| WO-1999020606-A2 | PIPERIDINES AND PIPERAZINES AS PLATELET AGGREGATION INHIBITORS | J. URIACH & CIA. S.A. (ES) | 1999-04-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064720-A1 | 2,6-Quinolinyl And 2,6-Naphthyl Derivatives, Processes For Preparing Them And Their Uses As Vla-4 Inhibitors | VCAM1, HRH4, LTA4H | SMN1; SMN2 4507/4885HIF1A 2406/4885CES1 960/4885 |
| US-20100105681-A1 | 2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES AS VLA-4 INHIBITORS | SCN4A, NECTIN4, VPS4B | SMN1; SMN2 3831/4885HIF1A 3415/4885CES1 628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.